Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study

View source ↗

Summary

Real-world evidence study evaluating adjunctive anti-seizure medication for epilepsy; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Epilepsy | Status: ACTIVE_NOT_RECRUITING